WCM-Q researcher wins prestigious international award
WCM-Q researcher wins prestigious international award
Stay updated with breaking news from Vascular Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WCM-Q researcher wins prestigious international award
- New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression - --Data Further Advances Understanding of VASCEPA/VAZKEPA Potential Mechanism
— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — --Data Further Advances Understanding of VASCEPA/VAZKEPA... | May 12, 2023
The intravenous delivery of immune-modulating cells may someday slow the expansion of bulges in the aorta, known as abdominal aortic aneurysms.
Abdominal aortic aneurysm, a weakening and ballooning of the aorta, the largest blood vessel in the body, may result in a life-threatening rupture. In a small, preliminary study examining a potential treatment to keep small abdominal aortic aneurysms from growing to a dangerous size, intravenous administration of immune-modulating cells resulted in a significant decrease in pro-inflammatory cells, and with higher doses, there was a decrease in aneurysm size.